The Enterprise Value as of December 2025 (TTM) for Meribank Biotech Co., Ltd (4724.TWO) is 2.57B

According to Meribank Biotech Co., Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 2.57B. This represents a change of -3.39% compared to the average of 2.66B of the last 4 quarters.

Meribank Biotech Co., Ltd (4724.TWO) Historical Enterprise Value (quarterly & annually)

How has 4724.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Meribank Biotech Co., Ltd over the last ten years is 2.00B. The current 2.57B Enterprise Value has changed 12.77% with respect to the historical average. Over the past ten years (40 quarters), 4724.TWO's Enterprise Value was at its highest in in the December 2024 quarter at 3.24B. The Enterprise Value was at its lowest in in the June 2022 quarter at 0.

Meribank Biotech Co., Ltd (4724.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Meribank Biotech Co., Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Meribank Biotech Co., Ltd (4724.TWO) Average Enterprise Value

How has 4724.TWO Enterprise Value performed in the past?

The current Enterprise Value of Meribank Biotech Co., Ltd (4724.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Meribank Biotech Co., Ltd (4724.TWO) Enterprise Value vs. Peers

How is 4724.TWO’s Enterprise Value compared to its peers?

Meribank Biotech Co., Ltd’s Enterprise Value is greater than NaviFUS Corp. (1.27B), greater than Chunghwa Chemical Synthesis & Biotech Co., Ltd. (2.47B), greater than Advagene Biopharma Co., Ltd. (1.76B), greater than Enimmune corporation (1.43B), greater than Genomics BioSci & Tech. Co.,Ltd. (2.25B), greater than GenMont Biotech Incorporation (1.61B), greater than Great Novel Therapeutics Biotech & Medicals (1.38B), greater than GeneReach Biotechnology Corp. (1.32B), greater than Sunny Pharmtech Inc. (2.44B), greater than Abnova (Taiwan) Corporation (1.04B),

Build a custom stock screener for Meribank Biotech Co., Ltd (4724.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Meribank Biotech Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Meribank Biotech Co., Ltd (4724.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Meribank Biotech Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.